Literature DB >> 1485930

Assessment of functional ability in Alzheimer disease: a review and a preliminary report on the Cleveland Scale for Activities of Daily Living.

M B Patterson1, J L Mack, M M Neundorfer, R J Martin, K A Smyth, P J Whitehouse.   

Abstract

Assessment of activities of daily living (ADL) in Alzheimer disease (AD) is critical in establishing the diagnosis, monitoring disease progression, evaluating the efficacy of treatment interventions, and determining the need for health and social services. The proper method to measure ADL depends on the purposes to which the scale is to be put. Existing ADL scales differ as to the type of behaviors assessed, the nature of the observations made, and the manner in which the observations are quantified. These scales were not specifically designed to evaluate changes in the nature and extent of the broad spectrum of functional difficulties seen in individuals with AD. We describe the Cleveland Scale for Activities of Daily Living (CSADL), an informant-based instrument designed to expand upon the capacity of existing physical and instrumental ADL scales by assessing both premorbid and current component acts (e.g., initiation versus implementation) of daily living functions.

Entities:  

Mesh:

Year:  1992        PMID: 1485930

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  8 in total

Review 1.  A review of quality of life in Alzheimer's disease. Part 2: Issues in assessing drug effects.

Authors:  S S Salek; M D Walker; A J Bayer
Journal:  Pharmacoeconomics       Date:  1998-12       Impact factor: 4.981

2.  The Reliability of Psychiatric Diagnosis Revisited: The Clinician's Guide to Improve the Reliability of Psychiatric Diagnosis.

Authors:  Ahmed Aboraya; Eric Rankin; Cheryl France; Ahmed El-Missiry; Collin John
Journal:  Psychiatry (Edgmont)       Date:  2006-01

3.  Functional impairment, healthcare costs and the prevalence of institutionalisation in patients with Alzheimer's disease and other dementias.

Authors:  Jerrold Hill; Howard Fillit; Simu K Thomas; Sobin Chang
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

4.  Biodistribution of Infused Human Umbilical Cord Blood Cells in Alzheimer's Disease-Like Murine Model.

Authors:  Jared Ehrhart; Donna Darlington; Nicole Kuzmin-Nichols; Cyndy D Sanberg; Darrell R Sawmiller; Paul R Sanberg; Jun Tan
Journal:  Cell Transplant       Date:  2015-09-25       Impact factor: 4.064

Review 5.  Conceptual evolution in Alzheimer's disease: implications for understanding the clinical phenotype of progressive neurodegenerative disease.

Authors:  Gregory A Jicha; Sarah A Carr
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

6.  Activities of daily living and quality of life in Alzheimer disease.

Authors:  J A Opara
Journal:  J Med Life       Date:  2012-06-18

Review 7.  Brain alterations and clinical symptoms of dementia in diabetes: aβ/tau-dependent and independent mechanisms.

Authors:  Naoyuki Sato; Ryuichi Morishita
Journal:  Front Endocrinol (Lausanne)       Date:  2014-09-05       Impact factor: 5.555

8.  Validation of the dementia care assessment packet-instrumental activities of daily living.

Authors:  Seok Bum Lee; Jeong Ran Park; Jeong-Hwa Yoo; Joon Hyuk Park; Jung Jae Lee; Jong Chul Yoon; Jin Hyeong Jhoo; Dong Young Lee; Jong Inn Woo; Ji Won Han; Yoonseok Huh; Tae Hui Kim; Ki Woong Kim
Journal:  Psychiatry Investig       Date:  2013-09-16       Impact factor: 2.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.